EGFR and non-small cell lung carcinoma: EGFR mutated NSCLC is a molecularly defined tumor subtype (~15-20% of adenocarcinomas of the lung) with peculiar clinic-pathological features: Asian ethnicity, female sex, adenocarcinoma histology and never smoking status [2, 5, 6].